×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Transom Capital Acquires SigmaTron International for $83 Million in Cash

  • May 21, 2025

Transom Capital - SigmaTron International Merger

Transom Capital Group, LLC entered a merger agreement on May 21, 2025, to acquire SigmaTron International, Inc. (SGMA) in a cash tender offer, valued at $83 million.

Deal Structure:

Under the terms of the agreement, an affiliate of Transom will commence a tender offer to acquire all outstanding shares of SigmaTron’s common stock for $3.02 per share in cash, representing a premium of 134.11% from the stock’s last close.

Company Profile:

SigmaTron is an independent provider of electronic manufacturing services (EMS), offering circuit board assemblies, full product builds, and related engineering, testing, and supply chain solutions to industries such as industrial, consumer, and medical electronics across North America and Asia.

Transom Capital Group is an operations-focused private equity firm based in El Segundo, California, specializing in middle-market investments across sectors such as industrials, consumer, business services, and technology. Founded in 2008, the firm manages over $900 million in assets under management.

Deal Details and Timeline:

The deal is expected to close during the third quarter of 2025.

SigmaTron International engaged Lincoln International for financial advisory services and retained Greenberg Traurig and Howard & Howard Attorneys for legal counsel. Transom Capital received legal counsel from Kirkland & Ellis.

Transom Capital is set to acquire SigmaTron at 0.03 times its sales.

Deal Metrics:

For a more in-depth look at this M&A transaction, please visit the Deal Metrics page here:

Deal Metrics for the acquisition of SigmaTron International, Inc. (SGMA) by Transom Capital Group, LLC

The Deal Metrics page for each merger or acquisition includes:

  • A spread history chart of the merger from announcement through eventual completion or failure.
  • Every event as the merger progresses through the expiration of the HSR period, various regulatory approvals, shareholder votes, etc.
  • News and SEC filings.
  • A history of deal updates.
  • And a whole lot more.

Disclaimer: Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.

Editor’s Note: Baranjot Kaur contributed to this article